sitem-insel AG

Cell therapies: Disruptive treatments require disruptive business models

Dr. Luc Henry, CEO and co-founder, Limula 

Dr. Henry will discuss the challenges associated with the production of highly personalized cancer treatments, such as CART cell therapies. He will introduce Limula, a startup company he founded in order to provide the technological means necessary to make these ‘living drugs’ broadly accessible. He will then describe how this project, and cell therapy in general, require to radically rethink treatment supply chain and business models.